about
Screening breast MR imaging in women with a history of chest irradiation.Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up.Screening breast MR imaging in women with a history of lobular carcinoma in situ.Patient follow-up after concordant histologically benign imaging-guided biopsy of MRI-detected lesions.Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.Lessons learned from MR-guided breast-biopsy.Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma.Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy.BI-RADS 3 for magnetic resonance imaging.MR imaging features of triple-negative breast cancers.Characteristics and outcome of enhancing foci followed on breast MRI with management implications.High-quality breast ultrasonography.Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes.Breast carcinoma in augmented breasts: MRI findings.Low energy mammogram obtained in contrast-enhanced digital mammography (CEDM) is comparable to routine full-field digital mammography (FFDM).Breast magnetic resonance imaging for screening high-risk women.Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer
P50
Q37843033-07F46233-6E7D-444F-856C-E43991CAC37EQ37919694-ED3DD2AC-F109-4786-9357-0CE2563550FBQ37928859-F8828CF2-772D-469E-BD78-EE9E3EE53E91Q38012727-5A60673D-2150-40BB-901D-75334C447F14Q38024596-AB93BA62-546F-4519-8165-FA1B6FB89F7FQ38053511-95B5C264-9B62-4810-AB2F-09D4982F9058Q38065712-66849156-6236-4966-ACF1-9C35E2C57F37Q38107657-6A5A954A-5331-43C2-AAC8-3AD76E3FBA6AQ38127526-ACF27061-8433-44A4-8A59-5D146F803ABDQ38135451-A0F3FC34-05D5-48E5-91AF-18532BB85FA3Q38200300-D9F84A38-E6A5-4887-80C7-3A12B3B032CFQ38209018-5CFB2D78-5FBD-4F44-B298-8F5A3C00B1D1Q38213516-7A5D076B-06B9-4A0D-911A-9DEFB4AD5372Q38438416-E0EB9D72-D9AD-48CE-9EC4-0E38C73C99D0Q40200663-3C4820AD-DE18-42EC-B01F-DE6A6CBD22A7Q43455014-02BBFF0C-740E-4423-BB38-327234D45C46Q92896555-4E096B96-5EFF-4259-93E6-D873AF39F259
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Janice S Sung
@ast
Janice S Sung
@en
Janice S Sung
@es
Janice S Sung
@nl
Janice S Sung
@sl
type
label
Janice S Sung
@ast
Janice S Sung
@en
Janice S Sung
@es
Janice S Sung
@nl
Janice S Sung
@sl
prefLabel
Janice S Sung
@ast
Janice S Sung
@en
Janice S Sung
@es
Janice S Sung
@nl
Janice S Sung
@sl
P106
P21
P31
P496
0000-0002-9067-9840
P569
2000-01-01T00:00:00Z